FGFR3 and glioblastoma: Regarding pathogenesis of the fusion, in glioblastoma, the FGFR3-TACC3 fusion has been shown to lose a regulatory site for miR-99a, an inhibitor of FGFR3, leading to enhanced expression of the gene fusion [30].